GSK measles vaccine gets U.S. FDA approval
msn.com
world
2022-06-06 08:15:00

(Reuters) -British drugmaker GSK said on Monday its vaccine, Priorix, was approved by the U.S. Food and Drug Administration (FDA) for the prevention of measles, mumps and rubella (MMR) in those aged one year and above. 
 

 Â© Reuters/DADO RUVIC Illustration of GSK logo

 The vaccine can be given as two doses, and may also be administered as a second shot to individuals who were previously vaccinated with a first dose of another MMR-containing vaccine, GSK said. Child vaccination rates in the United States fell during the COVID-19 pandemic as many children skipped doctor appointments and states eased vaccine requirements during remote learning, according to a government study https://www.
